bioRxivPathologyPreprint
Digital pathological classification of peripheral neuroblastic tumors across multi-continent cohorts
Yuanning ZhengiD, Yuichi Shibui, Balint Laszlo ForgoiD, Arlene H. NaranjoiD, Lisa WerriD, Janina Fischer-Mertens, Matthias FischeriD, Naonori KawakuboiD, Yoshinao OdaiD, Tatsuro TajiriiD, Mark A. ApplebaumiD, Hiroyuki ShimadaiD, Olivier GevaertiD, Bill ChiuiD
Abstract
Peripheral neuroblastic tumors (pNTs) are embryonal tumors of neural crest origin with highly variable clinical behaviors, ranging from spontaneous regression to aggressive and fatal disease. The International Neuroblastoma Pathology Classification (INPC) defines four diagnostic categories and stratifies tumors into Favorable Histology (FH) or Unfavorable Histology (UH) group based on age-linked assessment of tumor differentiation/maturation and the Mitosis-Karyorrhexis Index (MKI). Prognostic distinction according to INPC offers significant prediction of clinical outcomes, with patients harboring FH tumors demonstrating longer overall and event-free survival than those with UH tumor. Here, we assembled the largest multi-continental whole-slide histology imaging dataset of pNTs to date, comprising 2,030 tumors from the United States, Canada, Australia, New Zealand, Germany and Japan. Using this dataset, we developed NB-PathAssist, a computational pathology framework for automated INPC-based classification from digitized whole-slide images. NB-PathAssist integrates foundation-model-based feature extraction with an archetype-guided SummaryMixing architecture that compresses whole-slide morphology into representative histologic tokens for tumor-level classification. To automate MKI assessment, we manually annotated 14,049 nuclei, classifying them as mitotic-karyorrhectic (MK) tumor cells, non-MK tumor cells, or non-tumor cells. The resulting model was applied to phenotype cells in whole-slide images across 1,649 tissue sections. Across geographically and institutionally diverse cohorts, NB-PathAssist reproducibly assessed key diagnostic features and generated prognostic classifications concordant with reference INPC annotations. The average balanced accuracy for classifying tumor categories, grade of neuroblastic differentiation, MKI and prognostic groups achieved 0.84, 0.86, 0.89 and 0.96, respectively. We packaged the NB-PathAssist algorithms into an end-to-end online platform for scalable and standardized AI-assisted assessment of pNTs.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Pheno-MYCN maps the morphological footprint of MYCN amplification in paediatric neuroblastoma
Binghao Chai, Olga Fourkioti, … Chris Bakal·bioRxiv·Oct 9, 2026
- Stratified Immune Profiling Uncovers Prognostic Heterogeneity Beyond MYCN Amplification and Age in Neuroblastoma
Jessica Maria Magno, João C. D. Muzzi, … Mauro A. A. Castro·bioRxiv·Jul 21, 2026
- Normal Breast Tissue (NBT)-Classifiers: Advancing Compartment Classification in Normal Breast Histology
Siyuan Chen, Mario Parreno-Centeno, … Anita E. Grigoriadis·npj Breast CancerPeer-reviewed·Feb 9, 2026
- Single-cell RNA-sequencing of peripheral neuroblastic tumors reveals an aggressive transitional cell state at the junction of an adrenergic-mesenchymal transdifferentiation trajectory
X. Yuan, J. A. Seneviratne, … D. R. Carter·bioRxiv·May 15, 2020
- Automated and Manual Quantification of Tumour Cellularity in Digital Slides for Tumour Burden Assessment
S. Akbar, M. Peikari, … A. L. Martel·bioRxiv·Mar 12, 2019
- Identification of Malignant Peripheral Nerve Sheath Tumor subtypes with distinct genomic identities
Miriam Magallón‐Lorenz, Juana Fernández‐Rodríguez, … Bernat Gel·bioRxiv·Apr 2, 2026